Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
Harvard Business School
Cipla
Chubb
Fuji
Chinese Patent Office

Generated: August 24, 2019

DrugPatentWatch Database Preview

Litigation Details for JANSSEN PHARMACEUTICA, N v. v. KAPPOS (D.C. 2012)

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Small Molecule Drugs cited in JANSSEN PHARMACEUTICA, N v. v. KAPPOS
The small molecule drug covered by the patent cited in this case is ➤ Sign Up .

Details for JANSSEN PHARMACEUTICA, N v. v. KAPPOS (D.C. 2012)

Date Filed Document No. Description Snippet Link To Document
2011-09-09 1 Complaint assignee of United States Patent No. 7,741,356 ("the "356 Patent") seeking judicial review… The patent term adjustment for the '356 Patent, as set forth on the face of the patent, is 1009…administrative decision that the patent term adjustment for the '356 Patent, as authorized under 35 U.S.C…issuance of patents. The Director is the official responsible for determining the period of patent term adjustment…, and issued as the '356 Patent on June 22,2010. The '356 Patent is attached as Exhibit A. External link to document
2012-02-10 25 Memorandum & Opinion U.S. Patent No. 7,741,356 (“the patent” or “the ‘356 patent”), has sued the United States Patent and Trademark…Context After a patent application is submitted, a patent examiner with the United States Patent and Trademark…the patent statute, a patent's term is limited to 20 years, measured from the date the patent application… allowance, the patent will indicate the revised patent term adjustment, If the patent indicates or should… a 9B-day increase to the term of the ‘356 patent (“patent term” or “PTA"). Before the Court is defendants External link to document
2013-03-07 40 calculated the term of United States Patent No. 7,741,356 (“the ‘356 Patent”). Upon transfer of this action…challenged patent term adjustments embodied within that patent. Challenging a patent term adjustment…Director of the United States Patent and Trademark Office and the United States Patent and Trademark Office … Patent Terms & Adjustments Pursuant to 35 U.S.C. § 154(c)(1), the term of a patent filed…an application on which the patent’s priority date is based. Utility patents filed after June 8, 1995, External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
US Army
Daiichi Sankyo
Argus Health
Baxter
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.